Market Place
Sourcing Support
Algenex Announces GMP Certification
19 Apr 2022 //
GLOBENEWSWIRE
Algenex Announces Entry into the Food Technology Market
21 Mar 2022 //
GLOBENEWSWIRE
Algenex and Werfen renew their agreement to produce large-scale in vitro human
18 Nov 2021 //
PRESS RELEASE
Algenex, Biokit renew agreement for insect-based production in-vitro diagnostics
18 Nov 2021 //
BIOSPACE
Algenex, recognized as the best European company in the Animal Awards 2021
10 Nov 2021 //
PRESS RELEASE
Commercial Adoption of Herdscreen® ASFV Antibody Test in Europe
28 Oct 2021 //
PRESS RELEASE
Commercial Adoption of Herdscreen ASFV Antibody Test in Europe
28 Oct 2021 //
BIOSPACE
Algenex enters biocomponents market to provide mammalian-free production
30 Sep 2021 //
PRESS RELEASE
The EU and the United Kingdom validate Algenex`s Spanish CrisBio® technology
24 Sep 2021 //
PRESS RELEASE
Fatro secures European authorization for rabbit vaccine with Algenex tech
24 Sep 2021 //
PRESS RELEASE
Algenex’ CrisBio® platform validated by EU &UK mkt authorization for CrisBio
24 Sep 2021 //
PRESS RELEASE
EMA validates Algenex’ CrisBio® platform for the manufacturing of vaccines
22 Jun 2021 //
PRESS RELEASE
The CVMP of the European Medicines Agency has issued a +VE for the first vaccine
21 Jun 2021 //
PRESS RELEASE
Algenex and FATRO announce positive CVMP opinion for CrisBio-based vaccine
21 Jun 2021 //
PRESS RELEASE
Algenex incorporates Aroha Belén Sánchez as technical director and responsible
14 Jun 2021 //
PRESS RELEASE
Call notice for a shareholders’ meeting of ALTERNATIVE GENE EXPRESSION, S.L
14 Jun 2021 //
PRESS RELEASE
Open position: Technician Downstream Area
08 Jun 2021 //
PRESS RELEASE
Spain wants its vaccine against covid by 2022
25 Apr 2021 //
PRESS RELEASE
Technical Manager and Head of Quality Assurance and Quality Control
19 Apr 2021 //
PRESS RELEASE
Algenex, the Spanish biotechnology company that has accelerated its entry
29 Mar 2021 //
PRESS RELEASE
Algenex & Virbac sign international commercial licensing agreement for CrisBio®
22 Feb 2021 //
PRESS RELEASE
Algenex and Virbac sign an agreement to develop a vaccine for pigs
22 Feb 2021 //
PRESS RELEASE
Algenex & Virbac sign international commercial licensing agreement for CrisBio®
22 Feb 2021 //
PRESS RELEASE
We participate in Bio€quity Forum (May 17-19, 2021)
12 Feb 2021 //
PRESS RELEASE
Algenex selected as a finalist in Innovation Showcase
10 Feb 2021 //
PRESS RELEASE
Algenex selected as a finalist in Innovation Showcase
10 Feb 2021 //
PRESS RELEASE
The impact of COVID-19 on biotech: "At all times we have moved on, but now
27 Jan 2021 //
PRESS RELEASE
The Spanish company that wants to produce covid vaccines from a caterpillar
07 Oct 2020 //
PRESS RELEASE
The biotechnology company Algenex inaugurates a new plant for the production
25 Sep 2020 //
PRESS RELEASE
New plant to produce vaccines
25 Sep 2020 //
PRESS RELEASE
Algenex opens space to manufacture vaccines in Tres Cantos
25 Sep 2020 //
MADRIDESNOTICIA
Spain`s Algenex is looking for a partner to produce its covid vaccine
25 Sep 2020 //
ELECONOMISTA
Algenex closes a financing round of 7.4M and gives entry to Columbus Venture
25 Sep 2020 //
EUROPAPRESS
Algenex inaugura su nueva planta de fabricación de vacunas en Tres Cantos
24 Sep 2020 //
PRESS RELEASE
Algenex inaugurates its new vaccine manufacturing plant in Tres Cantos
24 Sep 2020 //
PRESS RELEASE
Algenex raises €7.4 million in financing round
13 Sep 2020 //
PRESS RELEASE
Algenex closes a new round of financing for 7.4 million to face its new projects
08 Sep 2020 //
PRESS RELEASE
JSC Olainfarm elects new Chairperson of the Management Board of Tonus Elast
21 Jul 2020 //
PRESS RELEASE
Algenex and Global DX announce positive evaluation of Herdscreen® ASFV
21 Jul 2020 //
PRESS RELEASE
Algenex promotes the creation of a technological platform for industrial vaccine
08 Jul 2020 //
PRESS RELEASE
World Zoonosis Day: More than 60% of human infectious diseases come from animals
08 Jul 2020 //
PRESS RELEASE
Olainfarm Interim report (Q1 and Q3) Operational and financial stability
01 Jun 2020 //
PRESS RELEASE
Algenex obtains financing from the CDTI to develop products against COVID-19
13 May 2020 //
PRESS RELEASE
In 2019, Olainfarm Group successfully started its transformation
06 May 2020 //
PRESS RELEASE
Algenex has developed an insect-based technology production of new vaccines
05 May 2020 //
PRESS RELEASE
Algenex advances insect-based vaccine production technology in human health
05 May 2020 //
PRESS RELEASE
In March Olainfarm group sales increased by 22%; manufacturing and distribution
20 Apr 2020 //
PRESS RELEASE
February sales in several markets exceeded prior year results; procedures
18 Mar 2020 //
PRESS RELEASE
Algenex to open new manufacturing facility and hunt for series C this year
02 Mar 2020 //
PRESS RELEASE
GRAM Opens Large-Scale Injectable Fill/Finish Facility
07 Feb 2020 //
CONTRACTPHARMA
Algenex adds to Fatro relationship with second vaccine license
02 Dec 2019 //
PRESS RELEASE
Algenex and FATRO sign commercial license for development of a second CrisBio®
02 Dec 2019 //
PRESS RELEASE
Convocatoria de Junta General Extraordinaria de socios
28 Oct 2019 //
PRESS RELEASE
First Algenex CrisBio®-based vaccine submitted to European Medicines Agency
15 Oct 2019 //
PRESS RELEASE
Bioinnovo, Algenex reinforce vaccine molecule arrangement
06 Oct 2019 //
PRESS RELEASE
Algenex SL Inaugurates Facility in Spain
24 Sep 2019 //
CONTRACTPHARMA
Algenex & Global DX sign agreement to develop and commercialize products
28 May 2019 //
PRESS RELEASE
BIOKIT licenses CRISBIO™ technology to make high quality recombinant proteins
29 Mar 2019 //
PRESS RELEASE
ALGENEX selected to present at the Animal Health Investment Innovation Showcase
22 Mar 2019 //
PRESS RELEASE
ALGENEX appoints new Strategic Advisory Board (SAB)
13 Mar 2019 //
PRESS RELEASE
